BioSig Technologies’ PURE EP platform surpasses 100 patient cases

BioSig Technologies announced that physicians have completed over 100 cases with the Near Field Tracking algorithm, an innovative and proprietary feature recently launched on the Company’s PURE EP Platform. “BioSig’s PURE EP Platform and its new algorithms are pioneering the way in the automatic interpretation of cardiac cellular reaction to catheter energy delivered,” commented Hicham El Masry, MD, FHRS, Cardiac Electrophysiologist at Mayo Clinic Arizona. “NFT is a unique algorithm for assessing lesion efficiency and increases my procedural efficiency and confidence when it comes to distinguishing between healthy and scar or ablated tissue. This revolutionary feature has become a critical tool during all my complex cases.”